I am hoping that people here can give me the benefit of their experience of switching from hydroxycarbamide to ruxolitinib.
I had a consultation today with Prof Mead at the Churchill hospital Oxford and he is suggesting that such a switch would be a good move.
Any feedback either positive or negative will be very welcome.
Thanks in anticipation.